The stock finds itself in an odd spot.
Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.
Albemarle is my top lithium play, benefiting from a potential lithium market turnaround and its status as the world's largest producer. The company's resilient management, strong cost controls, and recent earnings beats signal a swift recovery and future outperformance. Analysts remain overly bearish, but improving lithium prices and high short interest set up Albemarle for a potential short squeeze.
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Albemarle Corporation (NYSE:ALB, ETR:AMC) reported an unexpected second-quarter profit on Thursday, as steady demand for lithium used in electric vehicles and energy storage helped offset a volatile pricing environment. The US-based lithium producer posted adjusted earnings of $0.11 per share, beating analysts' expectations of a $0.78 loss.
Albemarle Corporation (NYSE:ALB ) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET Company Participants Jerry Kent Masters - Chairman, President & CEO Meredith H. Bandy - Vice President of Investor Relations & Sustainability Neal R.
ALB tops Q2 earnings estimates despite a 7% revenue dip, as lower lithium prices weigh on results.
The headline numbers for Albemarle (ALB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Albemarle (ALB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.83 per share. This compares to earnings of $0.04 per share a year ago.
Lithium has likely bottomed after a brutal selloff, with supply cuts and project halts setting the stage for a multi-year recovery. Albemarle is financially resilient, has cut costs, and trades near book value, offering a compelling risk/reward for contrarian investors. Supply/demand dynamics are improving, and lithium demand remains a secular trend, though macroeconomic and regulatory risks persist.
With new all-time high valuations for the S&P 500 and Nasdaq-100 in full swing, more and more investors are growing wary of buying new names for their portfolios, and for good reason. Buying near the top of the valuation cycle is always a scary thing.